Clinical Trial Update: A Pilot Study of the Use of Rituximab in the Treatment of Chronic Focal Encephalitis [Phase 1]

View source ↗

Summary

Phase 1 pilot trial evaluating rituximab for chronic focal encephalitis and Rasmussen's encephalitis. The study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Focal Encephalitis
• Rasmussen Encephalitis

Drugs mentioned

• Rituximab (rituximab)

Snippet

Sponsor: California Pacific Medical Center Research Institute | Conditions: Chronic Focal Encephalitis, Rasmussen's Encephalitis | Phase 1 | Status: COMPLETED